CD8+ T-cells are the main executor of anti-tumor immune response, and the reduced activation of CD8+ T-cells up-regulates the expression of programmed cell death protein 1 to promote T-cell exhaustion, destroy the immune homeostasis of T lymphocytes, and induce tumor cell escape [87, 88]. The gene discussed is CD8A; the disease is neoplasm.